Merrimack Pharmaceuticals Falls Back To Support Following JPMorgan Downgrade

By: via Benzinga
Merrimack Pharmaceuticals Inc (NASDAQ: MACK) shares are trading lower by $0.23 at $5.75 in Friday's session. The catalyst for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.